$MGLD
Marygold Companies, Inc. Stock $mgld

$mgld Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040591 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$8.457M	$8.236M
YoY Change	-3.59%	-7.71%
Cost Of Revenue	$2.091M	$2.037M
YoY Change	-6.27%	0.67%
Gross Profit	$6.366M	$6.198M
YoY Change	-2.68%	-10.16%
Gross Profit Margin	75.27%	75.26%
Selling, General & Admin	$6.023M	$5.807M
YoY Change	16.25%	20.16%
% of Gross Profit	94.61%	93.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$153.0K	$154.0K
YoY Change	212.48%	3.2%
% of Gross Profit	2.4%	2.48%
Operating Expenses	$7.363M	$7.235M
YoY Change	14.31%	18.16%
Operating Profit	-$997.0K	-$1.036M
YoY Change	-1095.86%	-233.35%
Interest Expense	$3.000K	$3.559K
YoY Change	-16.57%	-54.34%
% of Operating Profit
Other Income/Expense, Net	-$503.0K	$43.99K
YoY Change	-487.0%	-144.72%
Pretax Income	-$1.365M	-$802.8K
YoY Change	-572.12%	-210.96%
Income Tax	-$182.0K	-$303.0K
% Of Pretax Income
Net Earnings	-$1.183M	-$500.2K
YoY Change	-750.74%	-200.61%
Net Earnings / Revenue	-13.99%	-6.07%
Basic Earnings Per Share	-$0.03	-$0.01
Diluted Earnings Per Share	-$0.03	-$0.01
COMMON SHARES
Basic Shares Outstanding	39.38M shares	39.38M
Diluted Shares Outstanding	40.40M shares	40.40M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.61M	$20.29M
YoY Change	-1.65%	9.17%
Cash & Equivalents	$6.214M	$6.987M
Short-Term Investments	$12.40M	$13.30M
Other Short-Term Assets	$1.057M	$973.6K
YoY Change	43.65%	34.74%
Inventory	$2.389M	$2.195M
Prepaid Expenses		$949.1K
Receivables	$2.596M	$851.6K
Other Receivables	$0.00	$1.670M
Total Short-Term Assets	$26.25M	$27.29M
YoY Change	0.34%	7.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.502M	$1.911M
YoY Change	-0.83%	-19.8%
Goodwill	$2.307M	$2.307M
YoY Change	-0.01%	0.0%
Intangibles	$2.112M	$2.221M
YoY Change	-15.83%	-14.86%
Long-Term Investments		$500.0K
YoY Change		0.0%
Other Assets	$553.0K	$552.7K
YoY Change	0.06%	2.31%
Total Long-Term Assets	$8.679M	$8.176M
YoY Change	-4.12%	-14.12%
TOTAL ASSETS
Total Short-Term Assets	$26.25M	$27.29M
Total Long-Term Assets	$8.679M	$8.176M
Total Assets	$34.93M	$35.47M
YoY Change	-0.81%	1.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.803M	$2.450M
YoY Change	29.9%	86.45%
Accrued Expenses	$969.0K	$643.3K
YoY Change	48.26%	18.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$352.0K	$346.3K
YoY Change	954.52%	1012.37%
Total Short-Term Liabilities	$4.991M	$4.911M
YoY Change	18.7%	9.51%
LONG-TERM LIABILITIES
Long-Term Debt	$82.00K	$82.54K
YoY Change	-80.82%	-80.39%
Other Long-Term Liabilities	$582.0K	$352.4K
YoY Change	2.25%	-34.97%
Total Long-Term Liabilities	$906.0K	$677.2K
YoY Change	-27.94%	-44.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.991M	$4.911M
Total Long-Term Liabilities	$906.0K	$677.2K
Total Liabilities	$5.897M	$5.588M
YoY Change	7.96%	-2.1%
SHAREHOLDERS EQUITY
Retained Earnings	$16.40M	$17.59M
YoY Change	-6.8%	0.96%
Common Stock	$39.00K	$39.38K
YoY Change	-0.98%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.04M	$29.88M
YoY Change
Total Liabilities & Shareholders Equity	$34.93M	$35.47M
YoY Change	-0.81%	1.51%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.183M	-$500.2K
YoY Change	-750.74%	-200.61%
Depreciation, Depletion And Amortization	$153.0K	$154.0K
YoY Change	212.48%	3.2%
Cash From Operating Activities	-$850.4K	$292.3K
YoY Change	-714.41%	-66.75%
INVESTING ACTIVITIES
Capital Expenditures	$4.810K	$25.19K
YoY Change	-81.03%	-367.4%
Acquisitions
YoY Change
Other Investing Activities	$141.4K	-$1.511M
YoY Change	-60.39%	486.69%
Cash From Investing Activities	$136.6K	-$1.537M
YoY Change	-58.81%	475.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-17.34K	-$3.656K
YoY Change	88.68%	5.18%
NET CHANGE
Cash From Operating Activities	-850.4K	$292.3K
Cash From Investing Activities	136.6K	-$1.537M
Cash From Financing Activities	-17.34K	-$3.656K
Net Change In Cash	-731.1K	-$1.186M
YoY Change	-258.62%	-419.29%
FREE CASH FLOW
Cash From Operating Activities	-$850.4K	$292.3K
Capital Expenditures	$4.810K	$25.19K
Free Cash Flow	-$855.2K	$267.2K
YoY Change	-856.51%	-69.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001005101
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q3	MGLD	Increase Decrease In Purchase Consideration Payable IncreaseDecreaseInPurchaseConsiderationPayable		usd
CY2022Q3	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		usd
CY2023Q3	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	000-29913
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	THE MARYGOLD COMPANIES, INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1133909
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Calle Iglesia
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit B
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92672
CY2023Q3	dei	City Area Code CityAreaCode	949
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	429-5370
CY2023Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q3	dei	Trading Symbol TradingSymbol	MGLD
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39383459	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6987062	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8161167	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2194827	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2254139	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	1350165	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	991797	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	13261783	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	11480981	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	973562	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	904153	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	27288855	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	26818342	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	413454	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	425043	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1209739	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39383459	shares
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1255302	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	701248	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	821021	usd
CY2023Q3	us-gaap	Goodwill Goodwill	2307202	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2307202	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2220755	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2329970	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	771287	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	771287	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	552660	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	552660	usd
CY2023Q3	us-gaap	Assets Assets	35465200	usd
CY2023Q2	us-gaap	Assets Assets	35280827	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3491543	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2711931	usd
CY2023Q3	MGLD	Expense Waivers ExpenseWaivers	107213	usd
CY2023Q2	MGLD	Expense Waivers ExpenseWaivers	58685	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	361013	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	457309	usd
CY2023Q3	MGLD	Purchase Consideration Payable PurchaseConsiderationPayable	604990	usd
CY2023Q2	MGLD	Purchase Consideration Payable PurchaseConsiderationPayable	604990	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	346282	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	358802	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4911041	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4191717	usd
CY2023Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	82543	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	88516	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	352347	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	380535	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	242289	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	242289	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	677179	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	711340	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5588220	usd
CY2023Q2	us-gaap	Liabilities Liabilities	4903057	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	49	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	49	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39383459	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39383459	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39383459	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	39384	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	39384	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12490352	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12396722	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-239079	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-144840	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17586274	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18086455	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29876980	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30377770	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35465200	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35280827	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8235514	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8923288	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2037188	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	2023664	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6198326	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	6899624	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2589949	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2368368	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2248540	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1686658	usd
CY2023Q3	MGLD	Fund Operations Expense FundOperationsExpense	1270128	usd
CY2022Q3	MGLD	Fund Operations Expense FundOperationsExpense	1140588	usd
CY2023Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	972011	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	777710	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	153977	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149208	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7234605	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	6122532	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1036279	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	777092	usd
CY2023Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	193043	usd
CY2022Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	52569	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	3559	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	7794	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43993	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-98369	usd
CY2023Q3	MGLD	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	233477	usd
CY2022Q3	MGLD	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-53594	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-802802	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	723498	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-302621	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	226330	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500181	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497168	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397375	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40370659	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397375	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40399873	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500181	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497168	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-94239	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-313759	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-594420	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	183409	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30377770	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-94239	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93630	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500181	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29876980	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	29039274	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-313759	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6700	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497168	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497168	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	29229383	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500181	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497168	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	153977	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	149208	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	213	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	93630	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	6700	usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	269381	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-111855	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	128403	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	231070	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-478096	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	179083	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-4009	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-565296	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	359021	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-61872	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34198	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	194695	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	70130	usd
CY2022Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	34814	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	668487	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-149343	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-118480	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-233992	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	48528	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	70448	usd
CY2022Q3	MGLD	Increase Decrease In Purchase Consideration Payable IncreaseDecreaseInPurchaseConsiderationPayable	-22493	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	292348	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	879197	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25189	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9418	usd
CY2023Q3	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	7829645	usd
CY2023Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9341066	usd
CY2022Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	257624	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1536610	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-267042	usd
CY2023Q3	MGLD	Repayments Of Property And Equipment Loans RepaymentsOfPropertyAndEquipmentLoans	3656	usd
CY2022Q3	MGLD	Repayments Of Property And Equipment Loans RepaymentsOfPropertyAndEquipmentLoans	3476	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3656	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3476	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	62224	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-237331	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1185694	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	371348	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8586210	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13928899	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7400516	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14300247	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6987062	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13370714	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	413454	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	929533	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7400516	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14300247	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	4727	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	4018	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	86978	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	70557	usd
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_z8utnZa5lk23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zWaP9hp5yBf9">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	213	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1427	usd
CY2023Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_z4uvq38sUIl4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zFukDLub9poh"></span><span id="xdx_867_zf3ofsONA1ch">Major Customers and Suppliers – Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Marygold Companies, as a holding company, operates through its wholly-owned subsidiaries and has no concentration of risk either from customers or suppliers as a stand-alone entity. Marygold, as a newly formed development stage entity, had not commenced operations for the year ended June 30, 2023. Any transactions that did occur were combined with those of The Marygold Companies for periods prior to June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">Our subsidiary USCF Investments relies on the revenues generated through the various funds it manages. The concentration of fund management revenue for the three months ended September 30, 2023 and 2022, and related receivables as of September 30, 2023 and June 30, 2023 were as follows<span style="font-family: Adobe Clean DC">:</span></p> <p id="xdx_89B_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_z6O9VqpxNCH1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zGqCOnj9AkI8" style="display: none">SCHEDULE OF CONCENTRATION RISK</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-left: 0.25pt">Fund</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 38%; padding-left: 0.25pt">USO</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4GQ6mhsON57" style="width: 12%; text-align: right" title="Revenues">1,684,103</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zN8rrIV0yRsl" style="width: 12%; text-align: right" title="Concentration risk percentage">33</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zre3sQTZxWp4" style="width: 12%; text-align: right" title="Revenues">2,564,245</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zlxkVrKtARdd" style="width: 10%; text-align: right" title="Concentration risk percentage">47</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25pt">UNG</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zsKI5naEauv9" style="text-align: right" title="Revenues">1,688,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zw7nycZpBLd" style="text-align: right" title="Concentration risk percentage">34</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZKi6RZib0L7" style="text-align: right" title="Revenues">807,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zuDeVXJZXHak" style="text-align: right" title="Concentration risk percentage">15</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25pt">USCI</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zh3nSmb20NC6" style="text-align: right" title="Revenues">367,142</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember_zDNXhzCOsmXi" style="text-align: right" title="Concentration risk percentage">7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zscIcgp6QJNe" style="text-align: right" title="Revenues">597,385</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember_zMQSjsWXQzu2" style="text-align: right" title="Concentration risk percentage">11</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25pt">All Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuR3DAlMzsI9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,309,389</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zcvgzisTS6Pc" style="border-bottom: Black 1pt solid; text-align: right" title="Concentration risk percentage">26</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zcmhaIi3f4G8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,449,865</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zJFnTaRpRMpk" style="border-bottom: Black 1pt solid; text-align: right" title="Concentration risk percentage">27</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLe0jFHqqfSh" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,049,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zBVi1UkNO7Ik" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkSJOckQQMw7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,419,435</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_z7umZJeJWSL9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-left: 0.25pt">Fund</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 38%; padding-left: 0.25pt">USO</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNetCurrent_iI_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zskD9rjN7HMi" style="width: 12%; text-align: right" title="Accounts receivable">544,764</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zwKF2MwoVpP4" style="width: 12%; text-align: right" title="Concentration risk percentage">33</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNetCurrent_iI_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zug1nO53fnS1" style="width: 12%; text-align: right" title="Accounts receivable">596,039</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zPOp7ga0nGka" style="width: 10%; text-align: right" title="Concentration risk percentage">36</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25pt">UNG</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsReceivableNetCurrent_iI_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8lXDpJDtQbj" style="text-align: right" title="Accounts receivable">565,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zInDcCQdbfOk" style="text-align: right" title="Concentration risk percentage">34</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AccountsReceivableNetCurrent_iI_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zYLQKMuOxE8g" style="text-align: right" title="Accounts receivable">554,011</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zUJR3M9hjp26" style="text-align: right" title="Concentration risk percentage">33</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25pt">All Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iI_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zCItnlmKPoW" style="border-bottom: Black 1pt solid; text-align: right" title="Accounts receivable">559,662</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zd4X76ZvWAKa" style="border-bottom: Black 1pt solid; text-align: right" title="Concentration risk percentage">33</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AccountsReceivableNetCurrent_iI_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zT1yHnfEZqj7" style="border-bottom: Black 1pt solid; text-align: right" title="Accounts receivable">523,845</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zvoQSP5rNkK8" style="border-bottom: Black 1pt solid; text-align: right" title="Concentration risk percentage">31</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AccountsReceivableNetCurrent_iI_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkei0CS401Ik" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable">1,669,886</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zB51gWxYldIh" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iI_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z21uIRmBX5c" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable">1,673,895</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zrYGrWfhyTeh" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AA_zwiscbnyuJ42" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Marygold Companies, through Gourmet Foods and its wholly owned subsidiary, Printstock Products Limited, has two major customer groups comprising gross revenues: 1) baking, and 2) printing. For the purpose of segment reporting (Note 16), both revenue streams are considered part of the same “food industry” segment as they are evaluated as one segment by the Company’s Chief Operating Decision Maker.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Baking: </i>Within the baking sector there are three major customer groups; 1) grocery, 2) gasoline convenience stores, and 3) independent retailers. The grocery industry is dominated by several large chain operations, which are customers of Gourmet Foods, and there are no long-term guarantees that these major customers will continue to purchase products from Gourmet Foods, however, many of the existing relationships have been in place for sufficient time to give management reasonable confidence in their continuing business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the gasoline convenience store market customer group, Gourmet Foods supplies major consortiums of gasoline convenience stores who operate under various name brands. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The third major customer group is independent retailers and cafes, which collectively accounted for the balance of baking sales revenue. Although some customers contributed significant revenues to Gourmet Foods, no single customer contributed a significant amount of revenues to the consolidated Company for the three month periods ending September 30, 2023 and 2022. One customer did account for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zz6IsnjNnyAa" title="Concentration risk percentage">10</span>% of the Company’s consolidated accounts receivable as of September 30, 2023 and was insignificant as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Printing: </i>The printing sector of Gourmet Foods’ gross revenues is comprised of many customers, some large and some small, with no single customer accounting for a significant portion of the Company’s consolidated revenues. One customer accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--ProductOrServiceAxis__custom--PrintingSectorMember_zcyQApnGdXPf" title="Concentration risk percentage">17</span>% of the Company’s consolidated accounts receivable as of September 30, 2023 as compared to <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--ProductOrServiceAxis__custom--PrintingSectorMember_zDoafe8tjSr5" title="Concentration risk percentage">12</span>% as of June 30, 2023. One other customer accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--ProductOrServiceAxis__custom--PrintingSectorMember__srt--MajorCustomersAxis__custom--OneCustomerMember_z4ltjyLfc4i3" title="Concentration risk percentage">11</span>% of the Company’s consolidated accounts receivable as of June 30, 2023, however was insignificant as of September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gourmet Foods, including Printstock, is not dependent upon any one major supplier as many alternative sources are available in the local marketplace should the need arise. However, the unavailability of, or increase in price in, any of the ingredients on which Gourmet Foods relies to produce its products could harm its operating results for such period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Marygold Companies, through Brigadier, is partially dependent upon its contractual relationship with the alarm monitoring company who provides monitoring services to Brigadier’s customers. In the event this contract is terminated, Brigadier would be compelled to find an alternate source of alarm monitoring, or establish such a facility itself. Management believes that the contractual relationship is sustainable, and has been for many years, with alternate solutions available should the need arise. This monitoring company accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomersMember_zXpNMr7qKqO4" title="Concentration risk percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomersMember_zyIZrdfdS789" title="Concentration risk percentage">12</span></span>% of the Company’s consolidated accounts receivable as of September 30, 2023 and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_z3mjgIixttU" title="Concentration risk percentage">11</span>% at June 30, 2023. A customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zVNKe8aGvOTh" title="Concentration risk percentage">12</span>% of the Company’s consolidated accounts receivable as of June 30, 2023 and was insignificant as of September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brigadier purchases alarm panels, digital and analog cameras, mounting hardware and accessory items needed to complete security installations from a variety of sources. The manufacture of electronic items such as those sought by Brigadier has expanded to a global scale thus providing Brigadier with a broad choice of suppliers. Brigadier bases its vendor selection on several criteria including: price, availability, shipping costs, quality, suitability for purpose and the technical support of the manufacturer. Brigadier is not reliant on any one supplier.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Marygold Companies, through Original Sprout, sells its products through 3 channels to market: 1) direct sales to end users via online shopping carts, 2) sales through international wholesale distributors who, in turn, sell to other retailers or wholesalers, and 3) to retail stores selling to end users either from the shelf or online. No single customer contributed significant sales revenues to the Company’s consolidated revenues for the three months ended September 30, 2023 and 2022. No single customer contributed a significant amount to the Company’s consolidated accounts receivable as of September 30, 2023 or as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">The Marygold Companies, through Original Sprout, is dependent upon its relationships with product packaging companies who, at the direction of Original Sprout, produce the products in accordance with proprietary formulas, packages them in appropriate containers, and delivers the finished goods to Original Sprout for distribution to its customers. Original Sprout strives to maintain at least two packaging companies at all times, thus if one relationship were to fail the other would be able to continue to supply services. Because of the nature of the Original Sprout product ingredients, some of the ingredients may, at times, be difficult to source in timely fashion or at the expected price point. To safeguard against this possibility, Original Sprout endeavors to maintain at least a 90-day supply of all products in stock. Estimating and maintaining a reserve stock account is not a guarantee that a shortage of ingredient supplies will not affect production such that Original Sprout will not exhaust its reserves or be unable to fulfill customer orders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Marygold Companies, through Marygold UK and its wholly owned subsidiary, Tiger Financial and Asset Management (“Tiger”), identifies its concentration of risk as the reliance on a relatively small number of clients to continue their relationship with Tiger as their investment advisor. Tiger acts as an investment advisor and financial planner to its clients and has two principal revenue streams which comprise ongoing fees for providing investment advice, and commissions for the intermediation of insurance-based products. Tiger does not provide investment management services directly, rather the clients’ assets are referred to third party investment managers, primarily discretionary investment managers, and Tiger receives fees for the ongoing advice and financial planning services which are charged as a percentage of the assets under management. Should the relationship with the current investment manager come to an end, management is confident that a similar arrangement can be easily made with alternative investment managers. Tiger advises approximately 50 families/clients who collectively account for approximately $<span id="xdx_90F_eus-gaap--AssetsUnderManagementCarryingAmount_iI_pn6n6_c20230630__dei--LegalEntityAxis__custom--TigerFinancialAndAssetManagementLtdMember_zKMzY0oMkBkc">40 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in assets under management as of September 30, 2023 and June 30, 2023. No single client accounted for a significant portion of the Company’s consolidated revenues. Marygold UK does not recognize any credit risk for accounts receivable. Marygold UK is seeking to further diversify its client base through ongoing outreach initiatives and, in the long term, add to its revenue streams through the development of the Marygold fintech app.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q3	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock	-0.01
CY2023Q3	MGLD	Net Income Loss Available To Common And Preferred Stockholders Basic NetIncomeLossAvailableToCommonAndPreferredStockholdersBasic	-500181	usd
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29200	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-487958	usd
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39410175	shares
CY2023Q3	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	-0.01
CY2023Q3	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	-12223	usd
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987200	shares
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	1000000.0	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	800000	usd
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1237157	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397375	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-487958	usd
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39410175	shares
CY2023Q3	MGLD	Net Income Loss Available To Common Shareholders Diluted NetIncomeLossAvailableToCommonShareholdersDiluted	-487958	usd
CY2023Q3	MGLD	Weighted Average Numberof Shares Outstanding Preferredand Common Diluted WeightedAverageNumberofSharesOutstandingPreferredandCommonDiluted	39410375	shares
CY2023Q3	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	-0.01
CY2023Q3	MGLD	Net Income Loss Available To Preferred Stockholders Diluted NetIncomeLossAvailableToPreferredStockholdersDiluted	-12223	usd
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987200	shares
CY2023Q3	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	-0.01
CY2023Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-500181	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397375	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	485011	usd
CY2022Q3	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39383459	shares
CY2022Q3	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	0.01
CY2022Q3	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	0.01
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	12157	usd
CY2022Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987200	shares
CY2022Q3	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock	0.01
CY2022Q3	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	0.01
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497168	usd
CY2022Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred And Common Basic WeightedAverageNumberOfSharesOutstandingPreferredAndCommonBasic	40370659	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1259693	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1299564	usd
CY2023Q3	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	146920	usd
CY2023Q2	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	156050	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	788214	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	798525	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2194827	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2254139	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3235832	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3273711	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2026093	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2018409	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1209739	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1255302	usd
CY2023Q3	us-gaap	Depreciation Depreciation	44762	usd
CY2022Q3	us-gaap	Depreciation Depreciation	48581	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4413210	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4413210	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2192455	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2083240	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2220755	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2329970	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109215	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100627	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	324673	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	418625	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	306858	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	92417	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	92417	usd
CY2023Q3	MGLD	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	985765	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2220755	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2220755	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	973562	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	904153	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	949064	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	889128	usd
CY2023Q3	MGLD	Other Current Assets OtherCurrentAssets	24498	usd
CY2023Q2	MGLD	Other Current Assets OtherCurrentAssets	15025	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	973562	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	904153	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-266000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-112000	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	13300000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	11500000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	13136273	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	665424	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	539914	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	13261783	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	11606809	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	105295	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	231123	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11480981	usd
CY2023Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	500000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	500000	usd
CY2023Q3	MGLD	Equity Securities Without Readily Determinable Fair Value Ownership Percentage EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage	0.10	pure
CY2023Q2	MGLD	Equity Securities Without Readily Determinable Fair Value Ownership Percentage EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage	0.10	pure
CY2023Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2023	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2023Q3	MGLD	Deposits And Prepayments Of Rent DepositsAndPrepaymentsOfRent	52660	usd
CY2023Q2	MGLD	Deposits And Prepayments Of Rent DepositsAndPrepaymentsOfRent	52660	usd
CY2023Q3	us-gaap	Goodwill Goodwill	2307202	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2307202	usd
CY2023Q3	us-gaap	Goodwill Goodwill	2307202	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2307202	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2449564	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1325539	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	66680	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	97453	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	331968	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	454786	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	643331	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	834153	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3491543	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2711931	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39383459	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39383459	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39383459	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39383459	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.66	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.97	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y4M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.035	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.041	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.41
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	270000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.61
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	240881	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.18
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.64
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	490881	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.40
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y7M6D
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	205046	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	198487	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	701248	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	713360	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	328594	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	14151	usd
CY2023Q3	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Remainder Of Fiscal Year SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedRemainderOfFiscalYear	329882	usd
CY2023Q3	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Year One SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedYearOne	474180	usd
CY2023Q3	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Year Two SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedYearTwo	346121	usd
CY2023Q3	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Year Three SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedYearThree	176233	usd
CY2023Q3	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized After Year Three SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAfterYearThree	10290	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1336706	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y4M24D
CY2023Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	0	shares
CY2023Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	300000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-303000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	226000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	222898	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	18868	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	173972	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	18868	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	55193	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	18868	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	18868	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	64465	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	780657	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	154088	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	67297	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	45080	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	713360	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	109008	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M28D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0549	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2023Q3	MGLD	Finance Lease Annual Interest Rate FinanceLeaseAnnualInterestRate	0.0699	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.28	pure
CY2023Q3	MGLD	Penalties Payment PenaltiesPayment	2500000	usd
CY2023Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	60000	usd
CY2022Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	42000	usd
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	7	integer
CY2023Q3	us-gaap	Assets Assets	35465200	usd
CY2023Q2	us-gaap	Assets Assets	35280827	usd
CY2023Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	25189	usd
CY2022Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	9418	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	3235832	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	3273711	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2026093	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2018409	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1209739	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1255302	usd

Files In Submission

Name	View Source	Status
0001493152-23-040591-index-headers.html	Edgar Link	pending
0001493152-23-040591-index.html	Edgar Link	pending
0001493152-23-040591.txt	Edgar Link	pending
0001493152-23-040591-xbrl.zip	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.jpg	Edgar Link	pending
ex10-6_002.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mgld-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mgld-20230930_cal.xml	Edgar Link	unprocessable
mgld-20230930_def.xml	Edgar Link	unprocessable
mgld-20230930_lab.xml	Edgar Link	unprocessable
mgld-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGLD
Marygold Companies, Inc. Stock $mgld

2023 Q4 Form 10-Q Financial Statement

#000149315223040591 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGLD Marygold Companies, Inc. Stock $mgld

2023 Q4 Form 10-Q Financial Statement

#000149315223040591 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGLD
Marygold Companies, Inc. Stock $mgld